Trials / Recruiting
RecruitingNCT06322602
Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors
Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational trial evaluates the use of Ommaya reservoir placed during a biopsy to collect biomarkers longitudinally in patients with brain tumor. A biomarker is a measurable indicator of the severity or presence of the disease state. An Ommaya reservoir is a small device that's implanted under the scalp. It allows the doctor to take samples of cerebrospinal fluid (CSF) in the future without doing a spinal tap. The identification of biomarkers in CSF is rapidly emerging as a promising minimally invasive approach for monitoring tumor growth and response to therapy. In the future, these biomarkers may be used to help determine what treatments could be most effective and how well a tumor has responded to prior therapy. Currently, limited long-term access to CSF has made it difficult for studies to learn if collecting CSF at different points in the treatment process is useful. Having an Ommaya reservoir placed during a biopsy may allow for longitudinal biomarker collection in patients with brain tumor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Intracranial Catheter Placement | Undergo Ommaya reservoir placement |
| PROCEDURE | Lumbar Puncture | Undergo LP |
| PROCEDURE | Biopsy | Undergo biopsy |
| PROCEDURE | Biospecimen Collection | Undergo CSF sample collection |
| PROCEDURE | Computed Tomography | Undergo CT |
| PROCEDURE | Magnetic Resonance Imaging | Undergo MRI |
Timeline
- Start date
- 2024-02-28
- Primary completion
- 2029-03-01
- Completion
- 2029-03-01
- First posted
- 2024-03-21
- Last updated
- 2026-03-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06322602. Inclusion in this directory is not an endorsement.